680 related articles for article (PubMed ID: 17182967)
1. Cooperation between MASP-1 and MASP-2 in the generation of C3 convertase through the MBL pathway.
Møller-Kristensen M; Thiel S; Sjöholm A; Matsushita M; Jensenius JC
Int Immunol; 2007 Feb; 19(2):141-9. PubMed ID: 17182967
[TBL] [Abstract][Full Text] [Related]
2. The role of mannose-binding lectin-associated serine protease-3 in activation of the alternative complement pathway.
Iwaki D; Kanno K; Takahashi M; Endo Y; Matsushita M; Fujita T
J Immunol; 2011 Oct; 187(7):3751-8. PubMed ID: 21865552
[TBL] [Abstract][Full Text] [Related]
3. Activation of the lectin complement pathway in post-streptococcal acute glomerulonephritis.
Hisano S; Matsushita M; Fujita T; Takeshita M; Iwasaki H
Pathol Int; 2007 Jun; 57(6):351-7. PubMed ID: 17539966
[TBL] [Abstract][Full Text] [Related]
4. MASP-2, the C3 convertase generating protease of the MBLectin complement activating pathway.
Vorup-Jensen T; Jensenius JC; Thiel S
Immunobiology; 1998 Aug; 199(2):348-57. PubMed ID: 9777418
[TBL] [Abstract][Full Text] [Related]
5. Activation of the alternative complement pathway by mannose-binding lectin via a C2-bypass pathway.
Tateishi K; Matsushita M
Microbiol Immunol; 2011 Nov; 55(11):817-21. PubMed ID: 21831201
[TBL] [Abstract][Full Text] [Related]
6. Co-complexes of MASP-1 and MASP-2 associated with the soluble pattern-recognition molecules drive lectin pathway activation in a manner inhibitable by MAp44.
Degn SE; Jensen L; Olszowski T; Jensenius JC; Thiel S
J Immunol; 2013 Aug; 191(3):1334-45. PubMed ID: 23785123
[TBL] [Abstract][Full Text] [Related]
7. Production and purification of recombinants of mouse MASP-2 and sMAP.
Iwaki D; Fujita T
J Endotoxin Res; 2005; 11(1):47-50. PubMed ID: 15826378
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of the lectin pathway of complement with phage display selected peptides against mannose-binding lectin-associated serine protease (MASP)-1 and -2: significant contribution of MASP-1 to lectin pathway activation.
Kocsis A; Kékesi KA; Szász R; Végh BM; Balczer J; Dobó J; Závodszky P; Gál P; Pál G
J Immunol; 2010 Oct; 185(7):4169-78. PubMed ID: 20817870
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of complement activation and opsonophagocytosis by complexes of mannose-binding lectin with mannose-binding lectin-associated serine protease after binding to Staphylococcus aureus.
Neth O; Jack DL; Johnson M; Klein NJ; Turner MW
J Immunol; 2002 Oct; 169(8):4430-6. PubMed ID: 12370377
[TBL] [Abstract][Full Text] [Related]
10. Mannose-binding lectin (MBL)-associated serine protease (MASP)-1 contributes to activation of the lectin complement pathway.
Takahashi M; Iwaki D; Kanno K; Ishida Y; Xiong J; Matsushita M; Endo Y; Miura S; Ishii N; Sugamura K; Fujita T
J Immunol; 2008 May; 180(9):6132-8. PubMed ID: 18424734
[TBL] [Abstract][Full Text] [Related]
11. Assays for the functional activity of the mannan-binding lectin pathway of complement activation.
Thiel S; Møller-Kristensen M; Jensen L; Jensenius JC
Immunobiology; 2002 Sep; 205(4-5):446-54. PubMed ID: 12396006
[TBL] [Abstract][Full Text] [Related]
12. Mannan-binding lectin-associated serine protease (MASP)-1 is crucial for lectin pathway activation in human serum, whereas neither MASP-1 nor MASP-3 is required for alternative pathway function.
Degn SE; Jensen L; Hansen AG; Duman D; Tekin M; Jensenius JC; Thiel S
J Immunol; 2012 Oct; 189(8):3957-69. PubMed ID: 22966085
[TBL] [Abstract][Full Text] [Related]
13. Role of early lectin pathway activation in the complement-mediated killing of Trypanosoma cruzi.
Cestari Idos S; Krarup A; Sim RB; Inal JM; Ramirez MI
Mol Immunol; 2009 Dec; 47(2-3):426-37. PubMed ID: 19783051
[TBL] [Abstract][Full Text] [Related]
14. Leishmania (Viannia) braziliensis: interaction of mannose-binding lectin with surface glycoconjugates and complement activation. An antibody-independent defence mechanism.
Ambrosio AR; De Messias-Reason IJ
Parasite Immunol; 2005 Sep; 27(9):333-40. PubMed ID: 16149991
[TBL] [Abstract][Full Text] [Related]
15. Structural and functional overview of the lectin complement pathway: its molecular basis and physiological implication.
Matsushita M; Endo Y; Fujita T
Arch Immunol Ther Exp (Warsz); 2013 Aug; 61(4):273-83. PubMed ID: 23563865
[TBL] [Abstract][Full Text] [Related]
16. A novel measurement method for activation of the lectin complement pathway via both mannose-binding lectin (MBL) and L-ficolin.
Inoshita H; Matsushita M; Koide S; Kusaba G; Ishii M; Onda K; Gi MJ; Nakata M; Ohsawa I; Horikoshi S; Ohi H; Tomino Y
J Immunol Methods; 2009 Sep; 349(1-2):9-17. PubMed ID: 19699205
[TBL] [Abstract][Full Text] [Related]
17. Mannose-binding lectin (MBL) substitution: recovery of opsonic function in vivo lags behind MBL serum levels.
Brouwer N; Frakking FN; van de Wetering MD; van Houdt M; Hart M; Budde IK; Strengers PF; Laursen I; Houen G; Roos D; Jensenius JC; Caron HN; Dolman KM; Kuijpers TW
J Immunol; 2009 Sep; 183(5):3496-504. PubMed ID: 19657091
[TBL] [Abstract][Full Text] [Related]
18. The mannan-binding lectin pathway and lung disease in cystic fibrosis--disfunction of mannan-binding lectin-associated serine protease 2 (MASP-2) may be a major modifier.
Olesen HV; Jensenius JC; Steffensen R; Thiel S; Schiøtz PO
Clin Immunol; 2006 Dec; 121(3):324-31. PubMed ID: 17045845
[TBL] [Abstract][Full Text] [Related]
19. Toward a structure-based comprehension of the lectin pathway of complement.
Kjaer TR; Thiel S; Andersen GR
Mol Immunol; 2013 Dec; 56(4):413-22. PubMed ID: 23911397
[TBL] [Abstract][Full Text] [Related]
20. Prognosis in pediatric hematologic malignancies is associated with serum concentration of mannose-binding lectin-associated serine protease-2 (MASP-2).
Zehnder A; Fisch U; Hirt A; Niggli FK; Simon A; Ozsahin H; Schlapbach LJ; Ammann RA
Pediatr Blood Cancer; 2009 Jul; 53(1):53-7. PubMed ID: 19343776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
